Clinical Trial: Infant Malaria Vaccine Schedule Optimization

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879327) titled 'Infant Malaria Vaccine Schedule Optimization' on March 11.

Brief Summary: The aim of this study is to identify an optimal infant vaccine schedule for a malaria vaccine which is better aligned with the timing of other vaccine interventions.

Study Start Date: April 02

Study Type: INTERVENTIONAL

Condition: Malaria Vaccines

Intervention: BIOLOGICAL: R21 Matrix-M (R21/MM) Malaria Vaccine

Administered by intramuscular injection. Each 0.5 mL dose contains R21 Malaria Antigen (5 mcg) and Matrix-M1 (Adjuvant) (50 mcg).

BIOLOGICAL: Placebo

Administered by intramuscular injection. Each dose (0.5 mL) contains Normal saline (0.9%).

BI...